How does Immunome Inc (IMNM) change from a tortoise to a hare?

With 0.84 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.71 million shares. The 52-week range on IMNM shows that it touched its highest point at $30.96 and its lowest point at $4.44 during that stretch. It currently has a 1-year price target of $32.50. Beta for the stock currently stands at 1.69.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IMNM was down-trending over the past week, with a drop of -10.88%, but this was down by -15.95% over a month. Three-month performance surged to 99.91% while six-month performance rose 156.17%. The stock gained 323.56% in the past year, while it has gained 99.91% so far this year. A look at the trailing 12-month EPS for IMNM yields -5.38 with Next year EPS estimates of -2.16. For the next quarter, that number is -0.80. This implies an EPS growth rate of 66.48% for this year and -19.59% for next year.

Float and Shares Shorts:

At present, 59.69 million IMNM shares are outstanding with a float of 48.31 million shares on hand for trading. On Mar 15, 2024, short shares totaled 3.01 million, which was 5.26% higher than short shares on Feb 15, 2024. In addition to IMNN as the firm’s Imunon, Inc., IMNM serves as its Immunome, Inc.

Institutional Ownership:

Through their ownership of 39.34% of IMNM’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IMNM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, IMNM has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and IMNM currently yields $0.00. In the past year, IMNM’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, IMNM has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.